<DOC>
	<DOCNO>NCT00872196</DOCNO>
	<brief_summary>This follow-up study treatment sample collect .</brief_summary>
	<brief_title>A Follow-up Study Assess Resistance ABT-072 HCV-infected Subjects Administered ABT-072 Prior ABT-072 Studies</brief_title>
	<detailed_description>The purpose study evaluate development specific viral mutation response treatment ABT-072 .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Main Selection Criteria : A subject receive either ABT072 placebo prior study involve ABT072 . The investigator considers subject unsuitable study reason inclusive , limited , failure comply study procedure prior ABT072 clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>